SCHEMBL20893237

SCHEMBL20893237

CC(C)CN(C)c1ccc(Cl)cc1

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MEN1 O00255 1/20 0.43
KMT2A Q03164 1/20 0.43
RORC P51449 1/20 0.43
AOC3 Q16853 3/20 0.40
LMNA P02545 3/20 0.39
ALDH1A1 P00352 2/20 0.39
SLC6A4 P31645 2/20 0.39
KCNH2 Q12809 2/20 0.39
MAPT P10636 1/20 0.39
KDM4E B2RXH2 1/20 0.38
HPGD P15428 1/20 0.38
ALOX15 P16050 1/20 0.38
HSD17B10 Q99714 1/20 0.38
CHRNB2 P17787 1/20 0.38
CHRNB4 P30926 1/20 0.38
CHRNA3 P32297 1/20 0.38
CHRNA4 P43681 1/20 0.38
SLC6A2 P23975 2/20 0.38
SLC6A3 Q01959 2/20 0.38
CHKA P35790 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL23516584 0.83 KMT2A (0.39) MEN1KMT2ALMNAALDH1A1MAPT
SCHEMBL13841149 0.80 ALDH1A1 (0.48) MEN1KMT2AALDH1A1SLC6A4MAPT
SCHEMBL13223814 0.79 CHRM1 (0.43) MEN1KMT2ARORCAOC3LMNA
SCHEMBL15014119 0.78 APP (0.41) KMT2AAOC3ALDH1A1SLC6A4MAPT
SCHEMBL6872347 0.78 ESR1 (0.44) MEN1KMT2ALMNAALDH1A1MAPT
SCHEMBL7861342 0.77 CHRM1 (0.42) MEN1KMT2ARORCAOC3ALDH1A1
SCHEMBL1554057 0.77 HTR2A (0.48) MEN1KMT2AAOC3ALDH1A1KDM4E
Hydrochloric Acid SCHEMBL4458289 0.77 ESR1 (0.43) LMNASLC6A4MAPTALOX15SLC6A2
SCHEMBL20684149 0.77 TSHR (0.37) KMT2ARORCALDH1A1HPGD
SCHEMBL20893099 0.76 TAAR1 (0.48) RORCAOC3MAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10889556-B2 Compositions and methods for inhibiting influenza RNA polymerase PA endonuclease THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) 2021-01-12 US disclosed
US-20190106398-A1 COMPOSITIONS AND METHODS FOR INHIBITING INFLUENZA RNA POLYMERASE PA ENDONUCLEASE THE REGENTS OF THE UNIVERSITY OF CALIFORNIA 2019-04-11 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20190106398-A1 COMPOSITIONS AND METHODS FOR INHIBITING INFLUENZA RNA POLYMERASE PA ENDONUCLEASE POLRMT, RNASE1, POLM MEN1 3312/4885KMT2A 1216/4885RORC 2766/4885
US-10889556-B2 Compositions and methods for inhibiting influenza RNA polymerase PA endonuclease POLRMT, RNASE1, POLM MEN1 3312/4885KMT2A 1216/4885RORC 2766/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.